Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Surmodics Inc (SRDX)

Surmodics Inc (SRDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
SurModics: Fiscal Q3 Earnings Snapshot

SurModics: Fiscal Q3 Earnings Snapshot

SRDX : 39.40 (+0.25%)
SurModics: Fiscal Q2 Earnings Snapshot

SurModics: Fiscal Q2 Earnings Snapshot

SRDX : 39.40 (+0.25%)
SurModics: Fiscal Q1 Earnings Snapshot

SurModics: Fiscal Q1 Earnings Snapshot

SRDX : 39.40 (+0.25%)
SurModics: Fiscal Q4 Earnings Snapshot

SurModics: Fiscal Q4 Earnings Snapshot

SRDX : 39.40 (+0.25%)
SurModics: Fiscal Q3 Earnings Snapshot

SurModics: Fiscal Q3 Earnings Snapshot

SRDX : 39.40 (+0.25%)
Why Shares of Surmodics Jumped This Week

The company gained FDA marketing approval for a drug-coated balloon that will help clear blocked arteries.

SRDX : 39.40 (+0.25%)
Why Shares of Surmodics Soared on Tuesday

An analyst upgrade gave the stock a boost.

SRDX : 39.40 (+0.25%)
SurModics: Fiscal Q2 Earnings Snapshot

SurModics: Fiscal Q2 Earnings Snapshot

SRDX : 39.40 (+0.25%)
Surmodics Reports Second Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its second quarter ended March...

SRDX : 39.40 (+0.25%)
Surmodics Announces First Patient Enrolled in PROWL Registry Study Using the Pounceâ„¢ Thrombectomy System

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies, today announced enrollment of the first patient in PROWL, the Pounceâ„¢ Thrombectomy System Retrospective...

SRDX : 39.40 (+0.25%)

Barchart Exclusives

1 Bitcoin Stock to Buy and Hold for Long-Term AI Upside
Iris Energy offers prime investment potential in the Bitcoin industry backed by AI investments, record sales, and bullish analyst ratings. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar